79 European statups in new Y Combinator accelerator cohort

79 European statups in new Y Combinator accelerator cohort

Around 600 entrepreneurs are reportedly taking part in the latest accelerator cohort of US-based Y Combinator, of which, 13% are European founders.

There are 79 European founders taking part in the winter cohort, which is down from 85 in the summer cohort, according to a report from Sifted. While it is down from the summer, it is a slight increase on the previous winter cohort, which had 72 European founders.

A recent survey from Sifted, which polled 20 of the top European VCs, found that Entrepreneur First and Y Combinator are the only accelerators worth being involved with.

The latest cohort are urged to travel to San Francisco for the programme, but the accelerator is remote-friendly.

As part of the new cohort, Y Combinator said it would be investing $500,000 into participating startups.

One of the companies to announce its participation in the cohort is Versori. This is a UK-based no-code startup that builds integrations, workflow automations, data transformations and runs migrations for any data source, system, app or platform.

Its services are used across the finance, marketing, healthcare, manufacturing and retail segments. Finance businesses can leverage Versori to expedite customer onboarding, integrate accounting software and automate expenses.

Other SaaS-based startups in the cohort include Defer, Gluetrail, Depot, Trigger.dev and Ivy.

Other European companies in the accelerator are Quazel, which helps with learning languages, Sanvivo, a marketplace for pharmacies and GoodCourse, which offers training in TikTok-like videos.

Earlier in the year, Y Combinator-backed Angle Health secured $4m in its seed round. The company offers comprehensive health insurance plans that help startups save on costs.

Copyright © 2023 FinTech Global  

Enjoying the stories?

Subscribe to our daily FinTech newsletter and get the latest industry news & research


The following investor(s) were tagged in this article.